Telehealth Only • 480 Court St, Brooklyn, NY 11231
Tirzepatide Side Effects: Common, Rare & Long-Term Effects – Patient Guide
GoalBMI Wellness Physician-Reviewed Medical Content

Tirzepatide Side Effects: Complete Patient Guide

Author Sergey Terushkin, MD, FACSMedically Reviewed By Dr. Sergey Terushkin, MD, FACS Last Reviewed: June 2026Sources FDA, NEJM, NIH, SURMOUNT Trials, Mayo Clinic, PubMed

If you are thinking about starting tirzepatide, you have probably wondered what side effects to expect. That is one of the first questions patients ask during their consultation and for good reason. Understanding what is common, what usually improves with time, and when to call your provider can make starting treatment much less stressful.

This guide covers every tirzepatide side effect from the most commonly reported to the rare and serious along with practical guidance from our physician team at GoalBMI Wellness and evidence from the SURMOUNT clinical trials.

Patients considering physician-guided treatment can learn more about our Tirzepatide Program and Medical Weight Loss services at GoalBMI Wellness.

Quick Answer

The most common tirzepatide side effects are nausea, diarrhea, constipation, and vomiting. These symptoms are most common during the first few weeks of treatment and after dose increases. For most patients they are temporary clinical trial data shows that only a small percentage of patients stopped treatment because of them. Most people find that symptoms improve as the body adjusts.

Quick Facts

TopicDetails
Brand NamesMounjaro (for diabetes) and Zepbound (for weight loss) same active ingredient
Drug ClassDual GIP + GLP-1 Receptor Agonist the only medication in its class
Most Common Side EffectsNausea, diarrhea, constipation, vomiting mainly in early weeks
When Side Effects Are WorstFirst few weeks of treatment and after each dose increase
Do Side Effects Go Away?For most patients, yes symptoms improve significantly over time
FDA Boxed WarningThyroid C-cell tumors not for use with personal or family history of MTC or MEN 2
Telehealth SupportOngoing provider monitoring available through GoalBMI Wellness

What Is Tirzepatide?

Tirzepatide is a once-weekly injectable medication that works by activating two hormone receptors in the body GLP-1 and GIP. This dual-action approach is what makes it different from older GLP-1 medications like semaglutide, which target only one receptor.

By activating both receptors, tirzepatide helps regulate appetite signals in the brain, slows how quickly food leaves the stomach, and supports the body’s natural insulin response after eating. The result is a meaningful reduction in hunger and, for most patients, significant weight loss over time.

Because tirzepatide slows digestion a feature, not a flaw some patients experience gastrointestinal symptoms during the early adjustment period. Understanding why this happens helps put the side effects in context.

Diagram showing how tirzepatide activates both GLP-1 and GIP receptors to support appetite control, increase fullness, and promote weight loss.

Related: Semaglutide vs Tirzepatide Which Is Right for You?

Common and Serious Tirzepatide Side Effects

The following side effects have been reported in clinical trials and real-world use. Not every patient will experience all of these many patients have a very smooth experience, particularly at lower doses.

CategorySide EffectHow CommonWhen It Occurs
COMMONNauseaVery commonEarly weeks + dose increases
COMMONDiarrheaCommonEarly weeks + dose increases
COMMONConstipationCommonVaries throughout treatment
COMMONVomitingLess commonEarly weeks + dose increases
COMMONDecreased appetiteVery commonExpected therapeutic effect
COMMONStomach pain or bloatingCommonEarly weeks
COMMONHeartburn or acid refluxCommonAfter meals, early weeks
COMMONSulfur burps and gasCommon (indirect)Early weeks + dose increases
COMMONFatigueMild, some patientsEarly weeks
COMMONInjection site reactionsCommonAfter each injection
LESS COMMONHair sheddingSome patientsWith rapid weight loss
LESS COMMONVivid or unusual dreamsReported by patientsVariable
LESS COMMONFacial changesSome patientsWith significant weight loss
LESS COMMONRebound weight gainIf treatment is stoppedAfter discontinuation
SERIOUS (RARE)PancreatitisRareAny time
SERIOUS (RARE)Gallbladder diseaseRareWith rapid weight loss
SERIOUS (RARE)Kidney stressRare (dehydration-related)If severe GI symptoms
SERIOUS (RARE)Thyroid C-cell changesAnimal studies not confirmed in humansLong-term
SERIOUS (RARE)Severe allergic reactionsVery rareAny time

Gastrointestinal Side Effects Detailed Guide

Gastrointestinal symptoms are the most frequently reported side effects with tirzepatide. They happen because the medication slows gastric emptying the process by which food moves from the stomach into the small intestine. This is the same mechanism that helps patients feel full for longer. The body usually adapts over time.

Gastrointestinal symptoms are the most frequently reported side effects with tirzepatide

Nausea

Nausea is the most commonly reported tirzepatide side effect. It typically occurs during the first few weeks of treatment and after each dose increase, and improves significantly as the body adjusts to the medication. Eating smaller meals and avoiding fatty or spicy foods helps most patients manage it effectively.

Clinical Insight Karla K. Mioduchoski, FNP-BC

“Nausea is the side effect patients worry about most before starting tirzepatide. The good news is that for most patients it tends to peak during the first few weeks and gradually improves. Starting at a low dose and escalating slowly is one of the most effective ways to improve tolerability.”

Diarrhea

Diarrhea is more common during dose escalation periods when the body is adapting to a higher amount of medication. Staying hydrated is important if diarrhea is severe or prolonged, it can contribute to dehydration, which places stress on the kidneys.

Constipation

While diarrhea is more common, constipation is also frequently reported. Slower movement of food through the digestive tract can cause harder stools. Gradually increasing dietary fiber and drinking more water can help manage this.

Vomiting

Vomiting is less common than nausea but can occur, particularly during the early weeks or after dose increases. If vomiting prevents normal eating and drinking, contact your GoalBMI Wellness provider. Prolonged vomiting combined with inability to stay hydrated is a reason to seek care.

Provider Perspective Dr. Sergey Terushkin, MD, FACS

“Gastrointestinal side effects are the main reason some patients consider stopping treatment early. We always encourage patients to speak with their provider first. Most of these symptoms improve considerably with time, and simple adjustments to eating habits can make a meaningful difference.”

Lesser-Known Side Effects: Sulfur Burps, Vivid Dreams & Facial Changes

Beyond the well-known gastrointestinal symptoms, several side effects are widely reported by patients but receive less attention in standard medical literature.

Illustration highlighting lesser-known tirzepatide side effects, including sulfur burps, vivid dreams, and facial changes, with simple medical icons and before-and-after facial illustrations.

Sulfur Burps and Gas

Sulfur burps burps that smell like rotten eggs are an indirect side effect of tirzepatide that many patients experience but few expect. They occur because slowing gastric emptying gives more time for gas to form in the stomach. While unpleasant, sulfur burps are not harmful and tend to improve as the body adjusts.

Simple ways to help manage sulfur burps and gas:

  • Eat smaller, more frequent meals throughout the day
  • Avoid carbonated beverages, cruciferous vegetables, and high-fat foods
  • Ginger or peppermint tea may help ease digestive discomfort
  • Over-the-counter simethicone (Gas-X) may offer relief discuss with your provider first

Vivid or Unusual Dreams

Many patients using tirzepatide report experiencing vivid, intense, or unusual dreams. This is not listed in the official prescribing information for Mounjaro or Zepbound, and the direct cause is not fully established. If vivid dreams are affecting sleep quality, mention it to your provider during your next check-in.

Facial Changes

Some patients notice that their face looks thinner or has less fullness after significant weight loss on tirzepatide. This is a natural result of fat reduction throughout the body including the face and is not a direct pharmacological effect of the medication. If facial changes are a concern, your provider can discuss cosmetic options.

Patient Education Tip Karla K. Mioduchoski, FNP-BC

“These lesser-known side effects often come as a surprise because patients don’t read about them in the standard medication guides. We always walk patients through the full picture during their consultation so nothing feels unexpected.”

Injection Site Reactions

Common tirzepatide injection site reactions - GoalBMI Wellness

Injection site reactions are common with all subcutaneous injections. With tirzepatide, patients may notice redness, mild pain, itching, or small bumps at the injection site. These are usually mild and resolve within a few days.

Real-world data from the FDA’s adverse event reporting system identified injection-site pain as one of the most commonly reported issues by patients using tirzepatide. The good news is that simple technique adjustments significantly reduce discomfort.

Tips for reducing injection site reactions:

  • Rotate injection sites with every dose abdomen, thigh, or upper arm
  • Allow the pen to reach room temperature before injecting
  • Do not inject into areas of redness, bruising, or hardened skin
  • Use a slow, steady injection technique

From Our Medical Team Janna Goldfeld, PA-C

“Rotating injection sites is one of the simplest ways to reduce discomfort. Patients who inject in the same spot repeatedly tend to experience more noticeable reactions. We walk all our patients through the proper technique during their first telehealth consultation.”

Infographic illustrating rebound weight gain after stopping tirzepatide, showing how appetite may return, weight regain can occur, and healthy habits help maintain long-term results.

Rebound Weight Gain When Stopping Tirzepatide

Important to Know: Tirzepatide is intended for long-term use in patients with obesity or weight-related health conditions. Clinical data has shown that patients who stop tirzepatide tend to regain a significant portion of lost weight over time. This is not a side effect of stopping it reflects the chronic nature of obesity as a medical condition.

If you and your provider decide that discontinuing tirzepatide makes sense for you, maintaining the dietary habits and physical activity patterns established during treatment gives you the best chance of sustaining your results. Always work with your provider on a discontinuation plan rather than stopping abruptly.

Learn more: Medical Weight Loss Programs at GoalBMI Wellness

Serious and Rare Side Effects

The following side effects are uncommon but require prompt medical attention. Patients should understand these risks and know when to seek immediate care.


Pancreatitis

Inflammation of the pancreas has been reported in patients using tirzepatide. Symptoms include severe stomach pain that may radiate to the back, nausea, and vomiting. This requires immediate medical attention.

Gallbladder Disease

Gallstones and gallbladder inflammation have been reported, particularly in patients experiencing rapid weight loss. Symptoms include pain in the upper right abdomen, nausea, vomiting, and fever. Contact your provider if these symptoms develop.

Kidney Stress

Acute kidney injury has been reported, typically in patients who experienced severe vomiting or diarrhea that led to significant dehydration. Managing GI side effects promptly and staying well hydrated protects kidney function during treatment.

Thyroid C-Cell Changes FDA Boxed Warning

FDA BOXED WARNING: Tirzepatide carries an FDA boxed warning for thyroid C-cell tumors based on animal studies. This effect has not been confirmed in human clinical trials. Do not use tirzepatide if you or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Discuss your full family history with your provider before starting treatment.

Serious Allergic Reactions

Anaphylaxis and serious allergic reactions have rarely been reported. Seek emergency care immediately if you experience swelling of the face, lips, tongue, or throat, or difficulty breathing after injection.

Who Should Not Take Tirzepatide?

Your provider will evaluate your complete medical history before prescribing tirzepatide. Patients who should not use this medication include those with:

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • History of serious or recurring pancreatitis
  • Known allergy to tirzepatide or any component of the injection
  • Active gallbladder disease discuss with your provider
  • Pregnancy or planned pregnancy discuss safer alternatives with your provider

Not sure if you qualify? Review tirzepatide program eligibility and pricing

Tirzepatide Side Effects vs Semaglutide

Both tirzepatide and semaglutide are GLP-1 medications with similar side effect profiles. The main differences lie in weight loss results and mechanism of action.

Side EffectTirzepatideSemaglutideMore CommonNotes
NauseaCommon earlyCommon earlySimilarDose-dependent
DiarrheaCommonCommonSimilarBoth frequent
ConstipationCommonCommonSimilarBoth reported
Sulfur burpsReportedReportedSimilarGI slowing effect
Vivid dreamsReportedReportedSimilarNot in official labeling
Facial changesWith weight lossWith weight lossSimilarWeight loss effect
Injection reactionsCommonCommonSimilarRotate sites
FDA boxed warningThyroid YesThyroid YesSameBoth carry warning
Average weight loss~20-22% body weight~12-15% body weightTirzepatide winsSURMOUNT vs STEP trials

Full comparison: Semaglutide vs Tirzepatide Complete Comparison Guide

Timeline infographic showing common tirzepatide side effects from the first few days through long-term treatment, including nausea, bloating, constipation, and symptom improvement over time.

Tirzepatide Side Effects Timeline

TimelineWhat Most Patients Experience
Weeks 1-2Nausea most likely to begin. Appetite decreases noticeably. Injection site reactions possible. Some patients experience diarrhea or stomach discomfort.
Weeks 3-4First dose increase in many protocols. Temporary return of GI symptoms possible. Body begins to adapt. Some patients notice improvement already.
Month 2Most patients report reduced GI side effect severity. Diarrhea often improves. Constipation may persist for some. Second dose escalation period in some patients.
Month 3Many patients experience significantly fewer symptoms. Weight loss becomes more visible. Hair shedding may begin for patients with rapid weight loss.
Months 4-6Most patients well-adapted. GI side effects minimal for the majority. Maximum weight loss effects becoming apparent. Facial changes possible with significant loss.
OngoingSide effects rare and minimal for most patients at maintenance dose. Ongoing monitoring with your GoalBMI provider is recommended.

How to Reduce Tirzepatide Side Effects

Several practical strategies can help patients manage side effects during the adjustment period. None of these require prescription changes they are simple lifestyle adjustments that make a real difference.

StrategyHow It Helps
Eat smaller, frequent mealsReduces nausea by preventing the stomach from overfilling during slow gastric emptying
Avoid high-fat and spicy foodsFatty meals are processed more slowly and increase nausea risk during adjustment
Stay well hydratedEssential during diarrhea or vomiting to prevent dehydration and kidney stress
Remain upright after eatingStaying upright for 30+ minutes after meals reduces acid reflux and heartburn
Add fiber graduallyHelps relieve constipation increase slowly to avoid worsening symptoms
Follow dose escalation scheduleGradual dose increases allow the body to adapt never increase early without guidance
Rotate injection sitesReduces injection site reactions and discomfort with each dose
Communicate with your providerMany side effects can be managed with small adjustments never stop without guidance

Clinical Insight Dr. Sergey Terushkin, MD, FACS

“The patients who have the best experience with tirzepatide are the ones who stay in close contact with their care team. Most side effects are manageable with simple dietary adjustments and patience. The adjustment period is temporary the results are long-term.”

Explore our programs:

Tirzepatide Program

Semaglutide Program

Medical Weight Loss New York

Program Pricing

Frequently Asked Questions

What are the most common side effects of tirzepatide?

The most common tirzepatide side effects are nausea, diarrhea, constipation, and vomiting. These occur most often during the first few weeks of treatment and after dose increases. Clinical trial data shows that the large majority of patients continue treatment successfully through the adjustment period.

Does tirzepatide nausea go away?

For most patients, nausea from tirzepatide improves significantly after the first several weeks of treatment. Eating smaller meals, avoiding high-fat foods, and following the gradual dose escalation schedule all help. Nausea that persists beyond 6-8 weeks without improvement should be discussed with your provider.

What are sulfur burps and do they go away?

Sulfur burps burps that smell like rotten eggs happen because tirzepatide slows how quickly food leaves the stomach, giving more time for gas to form. They are not dangerous and usually improve as the body adjusts to the medication. Avoiding carbonated drinks, eating smaller meals, and reducing fatty foods can help.

Can tirzepatide cause vivid dreams?

Vivid or unusual dreams have been reported by many patients using tirzepatide. This is not listed in the official prescribing information and the cause is not fully understood. If vivid dreams are significantly affecting your sleep, mention it to your provider at your next check-in.

Will tirzepatide change my face?

Some patients notice their face looks thinner or has less fullness during tirzepatide treatment. This is caused by fat loss throughout the body including the face during significant weight reduction. It is a result of weight loss, not a pharmacological effect of the medication itself.

What happens if I stop taking tirzepatide?

Most patients who stop tirzepatide regain a portion of the weight they lost over time. Obesity is a chronic condition that benefits from long-term treatment. If discontinuation is the right choice for your situation, work with your provider on a plan to maintain your results through lifestyle modifications.

Is there a cancer risk with tirzepatide?

Tirzepatide carries an FDA boxed warning for thyroid C-cell tumors based on animal studies. However, a 2025 study in the Journal of the Endocrine Society found no confirmed association between tirzepatide and medullary thyroid cancer in humans. Patients with a personal or family history of MTC or MEN 2 should not use tirzepatide.

How does tirzepatide compare to semaglutide for side effects?

Both medications have very similar side effect profiles. The main differences are in weight loss outcomes tirzepatide produces greater average weight loss in clinical trials. Individual patients may tolerate one medication better than the other. Your GoalBMI provider can help you choose the right option based on your health history.

Can I take something for nausea while on tirzepatide?

Always consult your provider before taking any over-the-counter medications during tirzepatide treatment. Dietary adjustments resolve nausea for most patients. If they do not, your provider can recommend safe options and may consider adjusting your dose escalation pace.

When to Contact Your Provider

Meet Your Providers at GoalBMI Wellness featuring Dr. Sergey Terushkin, MD, FACS, Karla K. Mioduchoski, FNP-BC, and Janna Goldfeld, PA-C providing medical weight loss and telehealth care.

Most tirzepatide side effects do not require emergency care. However, patients should reach out to their GoalBMI Wellness provider promptly if they experience:

  • Severe nausea that does not improve with dietary adjustments after 2-3 weeks
  • Vomiting that prevents normal eating and drinking for more than 24 hours
  • Severe stomach pain, especially if it radiates to the back
  • Signs of dehydration dizziness, dark urine, significantly reduced urination
  • Swelling of the face, lips, tongue, or throat
  • Difficulty breathing after injection
  • Persistent constipation that does not respond to dietary changes
  • Any new symptoms you are not sure about when in doubt, reach out

Do not stop tirzepatide on your own without speaking with your provider first. Many side effects can be managed by adjusting eating habits, changing injection timing, or slowing the dose escalation pace. Stopping and restarting can make the adjustment period harder.

Final Thoughts

Most people beginning tirzepatide experience at least one mild digestive side effect during the first few weeks. While those symptoms can be frustrating, they usually improve as the body adjusts. Staying in touch with your healthcare provider, following the recommended dose schedule, and making small changes to eating habits often make a big difference. The goal isn’t simply getting through the first month it’s building a treatment plan you can stay with for the long term.

Provider Perspective Dr. Sergey Terushkin, MD, FACS

“Side effects from tirzepatide are real we don’t minimize them. But the patients who stay the course and work closely with their care team almost always get through the adjustment period and go on to achieve meaningful, lasting results. The temporary discomfort is worth understanding, not fearing.”

Continue Reading at GoalBMI Wellness:

Tirzepatide Program New York

Semaglutide Program New York

Semaglutide vs Tirzepatide Full Comparison

Medical Weight Loss New York

Program Pricing & Insurance

Insurance Verification

Medical References & Citations

This article was written using information from the following peer-reviewed studies, clinical guidelines, and authoritative medical sources:

#Citation
1Jastreboff A.M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 387(3), 205-216.
2Aronne L.J., et al. (2023). Continued Treatment with Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4). JAMA, 331(1), 38-48.
3Frías J.P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine, 385(6), 503-515.
4U.S. Food and Drug Administration. (2023). Zepbound (tirzepatide) prescribing information.
5U.S. Food and Drug Administration. (2022). Mounjaro (tirzepatide) prescribing information.
6Barnett M.J.L., et al. (2025). Tirzepatide and medullary thyroid cancer: No confirmed human association. Journal of the Endocrine Society.
7Real-World Safety Concerns of Tirzepatide: FAERS Data Analysis (2022-2025). PubMed Central.
8Wharton S., et al. (2021). Managing Gastrointestinal Side Effects of GLP-1 Receptor Agonists in Obesity. Postgraduate Medicine.
9National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Weight-loss & obesity medications. NIH.
10Mayo Clinic Staff. (2024). Tirzepatide side effects. Mayo Clinic.
11Obesity Medicine Association. (2023). Adult Obesity Clinical Practice Guidelines.
12Nauck M.A. & D’Alessio D.A. (2022). Tirzepatide: A dual GIP/GLP-1 receptor co-agonist. Cardiovascular Diabetology, 21(1), 169.

Medical Review

Author Sergey Terushkin, MD, FACS Board-Certified Family Nurse PractitionerMedically Reviewed By Dr. Sergey Terushkin, MD, FACS Board-Certified Surgeon & Medical Director Last Reviewed: June 2026

About GoalBMI Wellness

GoalBMI Wellness is a physician-guided telehealth platform providing medical weight loss, GLP-1 therapy, semaglutide programs, tirzepatide programs, peptide therapy, and wellness optimization services for eligible patients throughout New York. Patients do not need to visit a physical office. All consultations, prescriptions, and follow-ups are conducted remotely through secure telehealth appointments.

To learn more or schedule a consultation, visit wellness.goalbmi.com contact us page


Disclaimer

This article is intended for educational and informational purposes only. It does not constitute medical advice and should not replace consultation with a qualified healthcare provider. Treatment decisions should always be made in partnership with a licensed medical professional. Individual results vary, and no specific outcome is guaranteed. GoalBMI Wellness does not endorse any specific medication for use outside of a physician-supervised program.


Real Patient Transformations